{"title":"RETRACTION: Role of Mirnas in Lung Cancer","authors":"","doi":"10.1002/jcp.31519","DOIUrl":null,"url":null,"abstract":"<p><b>RETRACTION</b>: A. Uddin and S. Chakraborty, “Role of miRNAs in Lung Cancer,” <i>Journal of Cellular Physiology</i> (Early View), https://doi.org/10.1002/jcp.26607.</p><p>The above article, published online on 20 April 2018 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Robert Heath; and Wiley Periodicals LLC. The retraction has been agreed upon following an investigation into concerns raised by a third party, which revealed major textual overlap between this article and two previously published articles by different groups of authors elsewhere (Guz et al. 2014; Hubaux 2012).</p><p>The authors noted the major textual overlap and revised their manuscript during the proofing stage, yet the wrong version of the manuscript was published in Early View by mistake. The editors and the publisher apologize for this oversight. During the investigation, the authors were able to provide their revised article, however, also the revised version shows high textual and conceptual similarity to the two previously published review articles (Guz et al. 2014; Hubaux 2012). The authors disagree with the retraction.</p><p><b>References</b></p><p>Guz, M., A. Rivero-Müller, E. Okoń, et al. 2014. “Micrornas-Role in Lung Cancer.” Disease Markers 2014, no. 1: 1–13. https://doi.org/10.1155/2014/218169.</p><p>Hubaux, R. 2012. “Micrornas as Biomarkers for Clinical Features of Lung Cancer.” Journal of Postgenomics: Drug & Biomarker Development 2, no. 3: 1000108. https://doi.org/10.4172/2153-0769.1000108.</p>","PeriodicalId":15220,"journal":{"name":"Journal of Cellular Physiology","volume":"240 1","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcp.31519","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cellular Physiology","FirstCategoryId":"99","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jcp.31519","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
RETRACTION: A. Uddin and S. Chakraborty, “Role of miRNAs in Lung Cancer,” Journal of Cellular Physiology (Early View), https://doi.org/10.1002/jcp.26607.
The above article, published online on 20 April 2018 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Robert Heath; and Wiley Periodicals LLC. The retraction has been agreed upon following an investigation into concerns raised by a third party, which revealed major textual overlap between this article and two previously published articles by different groups of authors elsewhere (Guz et al. 2014; Hubaux 2012).
The authors noted the major textual overlap and revised their manuscript during the proofing stage, yet the wrong version of the manuscript was published in Early View by mistake. The editors and the publisher apologize for this oversight. During the investigation, the authors were able to provide their revised article, however, also the revised version shows high textual and conceptual similarity to the two previously published review articles (Guz et al. 2014; Hubaux 2012). The authors disagree with the retraction.
References
Guz, M., A. Rivero-Müller, E. Okoń, et al. 2014. “Micrornas-Role in Lung Cancer.” Disease Markers 2014, no. 1: 1–13. https://doi.org/10.1155/2014/218169.
Hubaux, R. 2012. “Micrornas as Biomarkers for Clinical Features of Lung Cancer.” Journal of Postgenomics: Drug & Biomarker Development 2, no. 3: 1000108. https://doi.org/10.4172/2153-0769.1000108.
期刊介绍：
The Journal of Cellular Physiology publishes reports of high biological significance in areas of eukaryotic cell biology and physiology, focusing on those articles that adopt a molecular mechanistic approach to investigate cell structure and function. There is appreciation for the application of cellular, biochemical, molecular and in vivo genetic approaches, as well as the power of genomics, proteomics, bioinformatics and systems biology. In particular, the Journal encourages submission of high-interest papers investigating the genetic and epigenetic regulation of proliferation and phenotype as well as cell fate and lineage commitment by growth factors, cytokines and their cognate receptors and signal transduction pathways that influence the expression, integration and activities of these physiological mediators. Similarly, the Journal encourages submission of manuscripts exploring the regulation of growth and differentiation by cell adhesion molecules in addition to the interplay between these processes and those induced by growth factors and cytokines. Studies on the genes and processes that regulate cell cycle progression and phase transition in eukaryotic cells, and the mechanisms that determine whether cells enter quiescence, proliferate or undergo apoptosis are also welcomed. Submission of papers that address contributions of the extracellular matrix to cellular phenotypes and physiological control as well as regulatory mechanisms governing fertilization, embryogenesis, gametogenesis, cell fate, lineage commitment, differentiation, development and dynamic parameters of cell motility are encouraged. Finally, the investigation of stem cells and changes that differentiate cancer cells from normal cells including studies on the properties and functions of oncogenes and tumor suppressor genes will remain as one of the major interests of the Journal.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
